Selected research
Industry Research
Dihydroartemisinin Tablets Industry Research Report 2026
Market perspective
The global Dihydroartemisinin Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dihydroartemisinin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dihydroartemisinin Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dihydroartemisinin Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dihydroartemisinin Tablets include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Schwitz Biotech, Ipca Laboratories, Centurion Healthcare and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dihydroartemisinin Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dihydroartemisinin Tablets Market by Company
KPC Pharmaceuticals
Guilin Nantang Pharmaceutical
Schwitz Biotech
Ipca Laboratories
Centurion Healthcare
AdvaCare Pharma
Dihydroartemisinin Tablets Segment by Type
Compound Dihydroartemisinin
Single Dihydroartemisinin
Dihydroartemisinin Tablets Segment by Application
Hospital Pharmacy
Retail Pharmacy
Dihydroartemisinin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydroartemisinin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dihydroartemisinin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydroartemisinin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dihydroartemisinin Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dihydroartemisinin Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dihydroartemisinin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Compound Dihydroartemisinin
- Single Dihydroartemisinin
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- KPC Pharmaceuticals
- Guilin Nantang Pharmaceutical
- Schwitz Biotech
- Ipca Laboratories
- Centurion Healthcare
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dihydroartemisinin Tablets Market Size (2021-2032)
- 2.2.2 Global Dihydroartemisinin Tablets Sales (2021-2032)
- 2.2.3 Global Dihydroartemisinin Tablets Market Average Price (2021-2032)
- 2.3 Dihydroartemisinin Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Compound Dihydroartemisinin
- 2.3.3 Single Dihydroartemisinin
- 2.4 Dihydroartemisinin Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dihydroartemisinin Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dihydroartemisinin Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Dihydroartemisinin Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Dihydroartemisinin Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Dihydroartemisinin Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dihydroartemisinin Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dihydroartemisinin Tablets, Product Type & Application
- 3.8 Global Manufacturers of Dihydroartemisinin Tablets, Established Date
- 3.9 Global Dihydroartemisinin Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 KPC Pharmaceuticals
- 4.1.1 KPC Pharmaceuticals Company Information
- 4.1.2 KPC Pharmaceuticals Business Overview
- 4.1.3 KPC Pharmaceuticals Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio
- 4.1.5 KPC Pharmaceuticals Recent Developments
- 4.2 Guilin Nantang Pharmaceutical
- 4.2.1 Guilin Nantang Pharmaceutical Company Information
- 4.2.2 Guilin Nantang Pharmaceutical Business Overview
- 4.2.3 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio
- 4.2.5 Guilin Nantang Pharmaceutical Recent Developments
- 4.3 Schwitz Biotech
- 4.3.1 Schwitz Biotech Company Information
- 4.3.2 Schwitz Biotech Business Overview
- 4.3.3 Schwitz Biotech Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio
- 4.3.5 Schwitz Biotech Recent Developments
- 4.4 Ipca Laboratories
- 4.4.1 Ipca Laboratories Company Information
- 4.4.2 Ipca Laboratories Business Overview
- 4.4.3 Ipca Laboratories Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio
- 4.4.5 Ipca Laboratories Recent Developments
- 4.5 Centurion Healthcare
- 4.5.1 Centurion Healthcare Company Information
- 4.5.2 Centurion Healthcare Business Overview
- 4.5.3 Centurion Healthcare Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio
- 4.5.5 Centurion Healthcare Recent Developments
- 4.6 AdvaCare Pharma
- 4.6.1 AdvaCare Pharma Company Information
- 4.6.2 AdvaCare Pharma Business Overview
- 4.6.3 AdvaCare Pharma Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio
- 4.6.5 AdvaCare Pharma Recent Developments
5 Global Dihydroartemisinin Tablets Market Scenario by Region
- 5.1 Global Dihydroartemisinin Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dihydroartemisinin Tablets Sales by Region: 2021-2032
- 5.2.1 Global Dihydroartemisinin Tablets Sales by Region: 2021-2026
- 5.2.2 Global Dihydroartemisinin Tablets Sales by Region: 2027-2032
- 5.3 Global Dihydroartemisinin Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Dihydroartemisinin Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Dihydroartemisinin Tablets Revenue by Region: 2027-2032
- 5.4 North America Dihydroartemisinin Tablets Market Facts & Figures by Country
- 5.4.1 North America Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dihydroartemisinin Tablets Sales by Country (2021-2032)
- 5.4.3 North America Dihydroartemisinin Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dihydroartemisinin Tablets Market Facts & Figures by Country
- 5.5.1 Europe Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dihydroartemisinin Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Dihydroartemisinin Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dihydroartemisinin Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dihydroartemisinin Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dihydroartemisinin Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dihydroartemisinin Tablets Market Facts & Figures by Country
- 5.7.1 South America Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dihydroartemisinin Tablets Sales by Country (2021-2032)
- 5.7.3 South America Dihydroartemisinin Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dihydroartemisinin Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dihydroartemisinin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dihydroartemisinin Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dihydroartemisinin Tablets Sales by Type (2021-2032)
- 6.1.1 Global Dihydroartemisinin Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Dihydroartemisinin Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Dihydroartemisinin Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Dihydroartemisinin Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dihydroartemisinin Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Dihydroartemisinin Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dihydroartemisinin Tablets Sales by Application (2021-2032)
- 7.1.1 Global Dihydroartemisinin Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Dihydroartemisinin Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Dihydroartemisinin Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Dihydroartemisinin Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dihydroartemisinin Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Dihydroartemisinin Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dihydroartemisinin Tablets Value Chain Analysis
- 8.1.1 Dihydroartemisinin Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dihydroartemisinin Tablets Production Mode & Process
- 8.2 Dihydroartemisinin Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dihydroartemisinin Tablets Distributors
- 8.2.3 Dihydroartemisinin Tablets Customers
9 Global Dihydroartemisinin Tablets Analyzing Market Dynamics
- 9.1 Dihydroartemisinin Tablets Industry Trends
- 9.2 Dihydroartemisinin Tablets Industry Drivers
- 9.3 Dihydroartemisinin Tablets Industry Opportunities and Challenges
- 9.4 Dihydroartemisinin Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst